Last reviewed · How we verify

NCT02781233

A Progressive Resistance Training Program in Patients With Haemophilia

Completed NA Last updated 18 October 2018
What this trial tests

NA trial testing Progressive resistance training in Haemophilia in 20 participants. Completed in 25 June 2018.

Timeline
24 October 2017
Primary endpoint
25 June 2018
25 June 2018

Quick facts

Lead sponsorUniversity of Valencia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment20
Start date24 October 2017
Primary completion25 June 2018
Estimated completion25 June 2018
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Valencia

Who can join

Adults 18 to 60, male only, with Haemophilia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the clinical impact of a progressive resistance training program in adults patients with haemophilia

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effectiveness of progressive moderate-vigorous intensity elastic resistance training on quality of life and perceived functional abilities in people with hemophilia: Secondary analysis of a randomized controlled trial.
    Cruz-Montecinos C, Pérez-Alenda S, Casaña J, Carrasco JJ, et al · · 2023 · cited 5× · PMID 36396600 · DOI 10.1111/ejh.13900

Verify or expand the search:

Other trials of Progressive resistance training

Trials testing the same drug.

Other University of Valencia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02781233.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing